Examine impressive results for simple, uncomplicated clot prevention
See extensive results for the most studied anticoagulant of its kind
View the direct inhibition of Factor Xa, an active area of research
Thromboembolic disorders pose life threatening risks to millions of patients
Connect with a world of events devoted to thromboembolic research
Learn more about ‘Xarelto’ and Thrombosis by watching videos and using interactive tools
04 - CCUS Lower Leg (Right)
06 - CCUS Lower Leg (Right) Performed From Front
Pooled Analysis of RECORD1, 2, and 3
Results of the Landmark RECORD Programme
'Xarelto' (rivaroxaban) - Most Studied Oral Direct Factor Xa Inhibitor
Desirable Characteristics of an Anticoagulant
01 - Introduction
08 - CCUS Lower Leg Muscles (Right)
10 - CCUS Gastrocnemius Muscle
12 - CCUS Tibia Vein Performed From Front
14 - Compression Maneuver Upper Leg (Right)
16 - Compression Maneuver Lower Leg (Right) 2
17 - Compression Maneuver Popliteal Vein (Right)
18 - Compression Maneuver Muscle Vein
05 - CCUS Lower Leg (Left)
07 - CCUS Lower Leg (Left) Performed From Front
09 - CCUS Lower Leg Muscles (Left)
11 - CCUS Soleus Muscle
13 - Breathing Maneuver Femoral Vein (Left)
15 - Compression Maneuver Lower Leg (Right) 1
20 - Compression Maneuver - Upper Leg Clot
19 - Compression Maneuver - Vessel Clot
21 - Compression Maneuver - Carve Vein Clot
22 - Compression Maneuver - Soleus Muscle Vein Clot
02 - CCUS Upper Leg (Right)
03 - CCUS Upper Leg (Left)